Douglas MacDougall is the President of MacDougall Biomedical Communications (MBI). Doug has been actively involved in the biotechnology industry for over 25 years and has provided strategic communications counsel and developed corporate communications plans for over 200 clients in the life sciences space. He speaks on topics related to crisis communications, investor relations, media relations and corporate positioning. Doug also assists many of his clients in fund raising, partnering and executive coaching. Doug has also been a consultant to the national Biotechnology Industry Organization for over 13 years and is the founder and leader of the BIO Executive Workshop Series on "Effectively Presenting to Investors", coaching over 1,200 life science CEOs around the world. Doug has been a member of the MIT Venture Mentoring Service for six years and is an Board Overseer at the Boston Museum of Science. Prior to founding MBI, Doug was Chief Financial Officer of Cetek Corporation and prior to that, Senior Vice President at Feinstein Kean Healthcare (FKH) where he built innovative corporate communications and investor relations programs for its biotechnology clients over a six-year period. Before joining FKH, Doug was Vice President of Finance and Administration of publicly-held Applied DNA Systems for a period of six years. Doug has a BS in Business Administration from the Rochester Institute of Technology.